Receptor-mediated biological processes: implications for evaluating carcinogens.
Silbergeld
E
E
Department of Epidemiology and Preventive Medicine, University of Maryland at Baltimore, 21201.
D000818:Animals; D015197:Carcinogenicity Tests; D002273:Carcinogens / Q000494:pharmacology / Q000633:toxicity; D016022:Case-Control Studies; D003043:Cocarcinogenesis; D015331:Cohort Studies; D004249:DNA Damage; D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000139:chemically induced / Q000453:epidemiology; D009374:Neoplasms, Experimental / Q000139:chemically induced; D000072317:Polychlorinated Dibenzodioxins / Q000009:adverse effects* / Q000494:pharmacology / Q000633:toxicity; D018336:Receptors, Aryl Hydrocarbon / Q000187:drug effects / Q000502:physiology; D018570:Risk Assessment
D002273:Carcinogens; D000072317:Polychlorinated Dibenzodioxins; D018336:Receptors, Aryl Hydrocarbon